Investing.com - Bayer (DE:BAYGN) reported on Monday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Bayer announced earnings per share of €2.67 on revenue of €12.85B. Analysts polled by Investing.com anticipated EPS of €2.52 on revenue of €12.58B. That with comparison to EPS of €2.55 on revenue of €13.02B in the same period a year before.Bayer had reported EPS of €1.29 on revenue of €10.75B in the previous quarter.Analysts are expecting EPS of €1.73 and revenue of €10.8B in the upcoming quarter.
Bayer shares are down 13% from the beginning of the year and are trading at €62.82 , down-from-52-week-high.They are under-performing the S&P Global (NYSE:SPGI) 100 which is down 10.75% year to date.
Bayer follows other major Healthcare sector earnings this month
Bayer's report follows an earnings beat by STRATEC Biomedical on Thursday, April 2, 2020, who reported EPS of €0.78 on revenue of €60.6M, compared to forecasts EPS of €0.71 on revenue of €60.00M.
Eckert&Ziegler AG had missed expectations on Tuesday, March 31, 2020 with first quarter EPS of €0.63 on revenue of €45.29M, compared to forecast for EPS of €0.72 on revenue of €46.90M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar